Compare ICICI Prudential Nifty Pharma Index Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹1000
₹500
Expense Ratio
1.05
2.3
NAV
₹17.61
₹292.68
Fund Started
25 Nov 2022
01 Aug 2005
Fund Size
₹104.67 Cr
₹1055.53 Cr
Exit Load
-
Exit load of 1% if redeemed within 30 days.
1 Year
6.43%
8.33%
3 Year
21.60%
24.87%
5 Year
-
13.99%
Equity
99.86%
98.67%
Cash
0.14%
1.32%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 22.89% |
Dr. Reddy's Laboratories Ltd. | 9.41% |
Divi's Laboratories Ltd. | 9.30% |
Cipla Ltd. | 8.47% |
Lupin Ltd. | 6.90% |
Torrent Pharmaceuticals Ltd. | 5.43% |
Laurus Labs Ltd. | 4.75% |
Aurobindo Pharma Ltd. | 4.49% |
Glenmark Pharmaceuticals Ltd. | 3.95% |
Alkem Laboratories Ltd. | 3.81% |
Sun Pharmaceutical Industries Ltd. | 9.99% |
Ajanta Pharma Ltd. | 6.40% |
Lupin Ltd. | 5.92% |
Glenmark Pharmaceuticals Ltd. | 4.04% |
Apollo Hospitals Enterprise Ltd. | 3.73% |
Gland Pharma Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.45% |
Divi's Laboratories Ltd. | 3.42% |
Alkem Laboratories Ltd. | 3.41% |
Fortis Healthcare Ltd. | 3.01% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
25 Nov 2022
01 Aug 2005
